Vanguard Group Inc Immucell Corp Call Options Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ICCC
# of Institutions
23Shares Held
1.15MCall Options Held
0Put Options Held
0-
Cresset Asset Management, LLC Chicago, IL264KShares$960,9670.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny149KShares$544,1390.0% of portfolio
-
Bleichroeder LP New York, NY102KShares$369,8020.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX72.7KShares$264,5620.0% of portfolio
-
Morgan Stanley New York, NY63.5KShares$231,1980.0% of portfolio
About IMMUCELL CORP
- Ticker ICCC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,746,860
- Market Cap $28.2M
- Description
- ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...